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An unusual skin and soft tissue infection of the lower 
limbs has been observed in immigrants from sub-Saharan 
Africa who cross the Atlantic Ocean crowded on small ﬁ  sh-
ing boats (pateras). Response to conventional treatment 
is usually poor. Extreme extrinsic factors (including new 
pathogens) may contribute to the etiology of the infection 
and its pathogenesis.
I
mmigration is increasing from poor-resourced coun-
tries into Spain and other European countries (1). From 
the coasts of Mauritania and Morocco, each year ≈10,000 
African people try to reach the coasts of the Canary Is-
lands or the southern Iberian Peninsula by sea, aboard 
small boats (called pateras) (2). These boats, normally 
used for ﬁ  shing, have capacity for only a few persons 
but these sea crossings are overcrowded with 40–50 per-
sons and with minimal water and food provisions. The 
journey lasts several days, during which travelers are 
exposed to extreme conditions, including cold weather; 
deﬁ  cient hygiene; prolonged sitting in the same position; 
and prolonged immersion of their feet in sea water possi-
bly contaminated by traces of feces, urine, decaying food, 
or fuel–water emulsions. On arrival, many need medical 
care for hypothermia and dehydration. However, despite 
efforts of authorities to prevent humanitarian disaster, fre-
quently these boats sink, and bodies are later found along 
the coast of the Canary Islands.
Among the varied medical problems affecting these 
young, previously healthy immigrants are unexpectedly 
high numbers of severe skin and soft tissue infections (SS-
TIs), especially those involving the feet and legs. Clinical 
characteristics of these SSTIs were unfamiliar to our de-
partment, even though our unit collaborates directly with 
vascular surgeons, endocrinologists, and dermatologists to 
manage diabetes-related foot infections. The clinical pic-
ture comprises a painful cellulitis with minimal or imper-
ceptible port of entry, deep abscesses, and tissue necrosis. 
Response to surgical debridement and broad-spectrum an-
timicrobial drugs is frequently poor, making amputation 
necessary in many cases. Here we describe the epidemiolo-
gy, clinical features, microbiology, treatment, and outcome 
of 7 patients affected with severe SSTIs of the foot and leg 
and discuss the pathogenic role of Shewanella algae as an 
etiologic agent in this syndrome.
The Study
The 7 patients were treated at our Unit of Infectious 
Diseases and Tropical Medicine at the Hospital Universi-
tario Insular of Las Palmas (Gran Canaria Island, Canary 
Islands, Spain). We deﬁ  ned the condition we call “patera 
foot” as all of the following: 1) acute SSTI involving the 
feet or legs, 2) direct relation of the infection to sea jour-
ney by overcrowded patera under extreme conditions, and 
3) good health status before travel. For this report, we ex-
cluded patients with diabetes, chronic arterial or venous leg 
disease, edema, or any other predisposing conditions.
We performed the following basic interventions for 
all patients: registry of epidemiologic data; complete clini-
cal history and physical examination; blood extraction for 
routine tests; blood cultures (if fever); cleaning and deb-
ridement of the affected area (if indicated by the vascular 
surgery team); and acquisition of cultures from the affected 
area by syringe (if abscess), skin punch (if cellulitis only), 
or deep infected tissue (if surgical debridement). Plastic 
surgery was performed when indicated. Amputation was 
carried out only after every effort was made to preserve the 
affected foot or leg.
All 7 patients whose conditions met the classiﬁ  cation 
criteria were young, black, sub-Saharan men (Table). In 
all patients, we ruled out a deﬁ  ned immunodeﬁ  ciency, 
speciﬁ   cally HIV infection; use of immunosuppressive 
agents; and indirect data suggesting primary immunode-
ﬁ   ciency (lymphopenia or immunoglobulin deﬁ  ciency). 
Organisms isolated from local specimens were gram-neg-
ative bacteria in all microbiologically positive cases. Four 
patients underwent amputation, including 1 transtibial 
and 1 transmetatarsal.
Patient 7, a 21-year-old man, was admitted to the inten-
sive care unit because of shock secondary to severe SSTI 
and intense dehydration with acute renal failure and rhab-
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domyolysis. Bilateral painful enlargement of his lower ex-
tremities was evident, with disseminated round ulcers and 
serohemorrhagic, conﬂ  uent blisters. The ulcers were cov-
ered with a ﬁ  brinoid, purulent exudate (Figure, panel A). 
After blood and skin samples were collected for culture, 
the patient began taking meropenem and linezolid . Skin 
samples grew gram-negative rods, initially identiﬁ  ed as S. 
putrefaciens by using the API 20E system (bioMérieux, 
Marcy l’Etoile, France). By using experimental work (3–5) 
that allows differentiation between Shewanella species, we 
identiﬁ  ed the organism as S. algae on the basis of its ca-
pacity to grow at 42ºC in 6.5% NaCl and to produce beta-
hemolysis. The organism displayed in vitro susceptibility 
to ceftazidime, meropenem, piperacilin/tazobactam, cipro-
ﬂ  oxacin, aminoglycosides, trimethoprim/sulfamethoxazole 
and aztreonam but resistance to amoxicilin/clavulamate, 
cefotaxime, and, notably, to imipenem (because S. algae is 
sensitive to other carbapenems i.e., meropenem). Four days 
after the patient was admitted to our unit, a large ﬂ  uctuant 
area appeared on the dorsum of his left foot; drainage from 
the area consisted of a grossly purulent, foul-smelling ma-
terial. Extensive debridement was necessary to control in-
fection (Figure, panel B); 1 month later, a skin allograft was 
implanted (Figure, panel C). The patient was discharged, 
asymptomatic, after 70 days of hospitalization.
Conclusions
During sea crossing by patera, immigrants are ex-
posed to extreme extrinsic conditions, such as cold weather 
and deﬁ  cient hygienic conditions. Intrinsic factors, such as 
limited skin compliance related to young age and possibly 
race, may play additional roles in the pathogenesis of this 
syndrome. Black race may be an intrinsic factor because, to 
our knowledge, immigrants of other ethnic origin (Magreb 
countries) have not developed this syndrome.
The presence of gram-negative bacteria in all case-
patients, especially S. algae in 1, instead of gram-positive 
cocci, indicates a source of infection related to water and 
illustrates the speciﬁ  c pathogenesis of this syndrome. Sh-
ewanella spp. are ubiquitous gram-negative bacteria; pos-
sible reservoirs include all types of water, oil emulsions, 
petroleum brines, protein-rich foods, and soil (5–7). Two 
Shewanella species, S. algae and S. putrefaciens, have been 
found in clinical specimens. Because automated systems 
are unable to distinguish between the 2 species, a number 
of infections attributed to S. putrefaciens probably cor-
respond to S. algae (4). S. algae is considered a rare op-
portunistic pathogen for humans, frequently involving im-
munocompromised hosts (6,8,9), and are usually part of 
a polymicrobial infection (6,10,11), which may mask its 
clinical importance. The presence of chronic leg ulcers in 
the context of peripheral vascular disease occurs common-
ly in adults with S. algae SSTI (6,10,12,13), and the afﬁ  nity 
of S. algae for necrotic or ischemic tissues has been well 
described (12,14,15).
The following sequence may explain why these young, 
previously healthy men developed such aggressive SSTIs. 
We speculate that speciﬁ  c etiologic agents (mainly GNB, 
including S. algae) present in densely contaminated water 
enter through macerated skin, then reach deep tissues that 
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Table. Clinical characteristics of 7 black male immigrants to Spain who developed severe skin and soft tissue infections (patera foot) 
following sea crossing from Africa on small boats (pateras)
Patient no. Age, y Country of origin Isolated organism Outcome
1 20 Ghana Unknown Transtibial amputation
2 38 Guinea Morganella morganii 5th toe amputation
3 16 Mali Proteus vulgaris 4th toe amputation
4 36 Guinea Bissau Enterobacter cloacae, Serratia spp. No amputation
5 27 Togo Unknown No amputation
62 0 G a m b i a Escherichia coli Transmetatarsal amputation
7 21 Côte d’Ivoire Shewanella algae No amputation; skin allograft
Figure. Progression of infection (patera foot) in case-patient 7, a previously healthy 21-year-old immigrant from sub-Saharan Africa who 
reached Spain by sea crossing on a small boat (patera). A) Initial severe skin and soft tissue infection of the lower limbs; B) extensive 
debridement of the left foot; C) left foot after skin allograft.have been submitted to subacute ischemia from overpres-
sure and deﬁ  cient venous drainage, both related to forced, 
prolonged sitting. The ensuing inner inﬂ  ammation, expand-
ing against a young skin with limited compliance, further 
aggravates the ischemia and leads to necrosis, probably by 
a compartmental-like mechanism.
These cases appear to represent a new syndrome, with 
speciﬁ  c etiology, pathogenesis, clinical features, and re-
sponse to treatment. GNB, including S. algae, are involved, 
and an ischemic mechanism may be crucial in the develop-
ment of these destructive infections. The initial election of 
empirical therapy, always covering those pathogens, and 
early surgical evaluation are crucial in preventing major 
disability in these young people.
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